EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of growth hormone adjuvant treatment on oocyte retrieval in patients with poor ovarian response and no viable embryos in previous in vitro fertilization (IVF) cycles

Liang Gao, Yuting Zhang, Mengyun Li, Jingyu Zhang, Jianjun Zhou

PeerJ · 16.03.2026 · 14 · e21000

DOI: 10.7717/peerj.21000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 16.03.2026. Verfasst von Liang Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drum Tower Clinic Medical College of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Fertilization in Vitro, Oocyte Retrieval, Ovulation Induction, Growth Hormone. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nanjing Medical University Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the efficacy of growth hormone (GH) as an adjuvant treatment for enhancing embryo quantity in patients with poor ovarian response (POR) who previously had no viable embryos in in vitro fertilization (IVF) cycles.

Methods

A total of 86 POR patients with no viable embryos in their first IVF cycles were enrolled. Among them, 43 patients in the study group received GH adjuvant treatment during their second IVF cycle, while the remaining 43 patients in the control group did not receive GH. Clinical characteristics were compared between the GH+ and GH− cycles within the study group, and further comparisons were made between the study and control groups regarding clinical characteristics and IVF outcomes.

Results

Self-controlled analysis showed that GH adjuvant treatment significantly increased the number of oocytes retrieved ( P = 0.010), bipronuclear (2PN) embryos ( P = 0.007), and transferable embryos ( P < 0.001) in the study group. Compared to the control group, study group had a higher number of oocytes retrieved ( P = 0.029) and a higher luteinizing hormone (LH) level on the HCG trigger day ( P = 0.049). Multivariate logistic regression analysis identified LH level on the HCG trigger day in the GH cycle as an independent factor associated with increased oocyte retrieval (OR: 1.149, 95% CI [1.007–1.310], P = 0.038).

Conclusion

GH adjuvant treatment may improve the number of oocytes retrieved in POR patients who previously had no viable embryos in IVF cycles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertilization in VitroOocyte RetrievalOvulation InductionGrowth HormoneHumansFemaleAdultPregnancyLuteinizing HormoneEmbryo Transfer

Stichwörter der Autor:innen

Growth hormoneLuteinizing hormonePoor ovarian responseTransferable embryo

Substanzen

Growth HormoneLuteinizing Hormone

Autor:innen und Institutionen

  • Drum Tower Clinic Medical College of Nanjing Medical University, Nanjing, China.
  • The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
  • Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Förderung

  • National Natural Science Foundation of China
  • Nanjing Medical University Science and Technology Development Fund

Zitieren

APA

Gao, L., Zhang, Y., Li, M., Zhang, J., & Zhou, J. (2026). Effect of growth hormone adjuvant treatment on oocyte retrieval in patients with poor ovarian response and no viable embryos in previous in vitro fertilization (IVF) cycles. PeerJ, 14, e21000. https://doi.org/10.7717/peerj.21000

Vancouver

Gao L, Zhang Y, Li M, Zhang J, Zhou J. Effect of growth hormone adjuvant treatment on oocyte retrieval in patients with poor ovarian response and no viable embryos in previous in vitro fertilization (IVF) cycles. PeerJ. 2026;14:e21000. doi:10.7717/peerj.21000

BibTeX
@article{Gao2026,
  author = {Gao, Liang and Zhang, Yuting and Li, Mengyun and Zhang, Jingyu and Zhou, Jianjun},
  title = {Effect of growth hormone adjuvant treatment on oocyte retrieval in patients with poor ovarian response and no viable embryos in previous in vitro fertilization (IVF) cycles},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21000},
  doi = {10.7717/peerj.21000}
}
Kostenlos starten →